MASS Fundamental Analysis - 908 DEVICES INC

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to MASS. MASS was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for MASS as it has an excellent financial health rating, but there are worries on the profitability. MASS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

MASS had negative earnings in the past year.

MASS had a negative operating cash flow in the past year.

In the past 5 years MASS always reported negative net income.

MASS had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

MASS's Return On Assets of -9.02% is on the low side compared to the rest of the industry. MASS is outperformed by 63.71% of its industry peers.

MASS has a Return On Equity of -11.09%. This is comparable to the rest of the industry: MASS outperforms 41.13% of its industry peers.

		Industry Rank	Sector Rank
ROA	-9.02%
ROE	-11.09%
ROIC	N/A

ROA(3y)-25.68%

ROA(5y)-18.55%

ROE(3y)-34.2%

ROE(5y)-24.45%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MASS has a better Gross Margin (49.60%) than 87.10% of its industry peers.

MASS's Gross Margin has improved in the last couple of years.

MASS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	49.6%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.03%

GM growth 5Y2.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MASS does not have a ROIC to compare to the WACC, probably because it is not profitable.

MASS has more shares outstanding than it did 1 year ago.

MASS has more shares outstanding than it did 5 years ago.

There is no outstanding debt for MASS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MASS has an Altman-Z score of 3.42. This indicates that MASS is financially healthy and has little risk of bankruptcy at the moment.

MASS has a Altman-Z score (3.42) which is comparable to the rest of the industry.

MASS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.42

ROIC/WACCN/A

WACC9.45%

2.3 Liquidity

MASS has a Current Ratio of 7.62. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.

MASS has a better Current ratio (7.62) than 87.90% of its industry peers.

MASS has a Quick Ratio of 6.97. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 6.97, MASS belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.62
Quick Ratio	6.97

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MASS have decreased by -3.74% in the last year.

MASS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.06%.

MASS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.11% yearly.

EPS 1Y (TTM)-3.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%15.15%

Revenue 1Y (TTM)21.06%

Revenue growth 3Y12.21%

Revenue growth 5Y27.11%

Sales Q2Q%17.88%

3.2 Future

Based on estimates for the next years, MASS will show a very strong growth in Earnings Per Share. The EPS will grow by 22.96% on average per year.

MASS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.

EPS Next Y34.05%

EPS Next 2Y22.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-4.98%

Revenue Next 2Y7.69%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MASS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MASS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MASS's earnings are expected to grow with 22.96% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y22.96%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MASS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

908 DEVICES INC

NASDAQ:MASS (7/28/2025, 8:00:00 PM)

After market: 7.33 0 (0%)

7.33

-0.09 (-1.21%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)05-13 2025-05-13/bmo

Earnings (Next)08-05 2025-08-05/bmo

Inst Owners72.92%

Inst Owner Change-0.24%

Ins Owners5.58%

Ins Owner Change0.94%

Market Cap262.85M

Analysts84

Price Target5.61 (-23.47%)

Short Float %6.57%

Short Ratio3.77

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-21.57%

Min EPS beat(2)-58.68%

Max EPS beat(2)15.54%

EPS beat(4)3

Avg EPS beat(4)19.94%

Min EPS beat(4)-58.68%

Max EPS beat(4)113.88%

EPS beat(8)7

Avg EPS beat(8)18.98%

EPS beat(12)9

Avg EPS beat(12)11.59%

EPS beat(16)11

Avg EPS beat(16)8.01%

Revenue beat(2)1

Avg Revenue beat(2)4.81%

Min Revenue beat(2)-2.97%

Max Revenue beat(2)12.6%

Revenue beat(4)2

Avg Revenue beat(4)0.28%

Min Revenue beat(4)-10.3%

Max Revenue beat(4)12.6%

Revenue beat(8)5

Avg Revenue beat(8)3.04%

Revenue beat(12)7

Avg Revenue beat(12)2.61%

Revenue beat(16)11

Avg Revenue beat(16)3.53%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-7.84%

EPS NQ rev (3m)20.29%

EPS NY rev (1m)7.41%

EPS NY rev (3m)20.21%

Revenue NQ rev (1m)-1.34%

Revenue NQ rev (3m)-1.28%

Revenue NY rev (1m)-0.06%

Revenue NY rev (3m)-1.52%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.28
P/FCF	N/A
P/OCF	N/A
P/B	1.65
P/tB	2.16
EV/EBITDA	N/A

EPS(TTM)-1.11

EYN/A

EPS(NY)-0.57

Fwd EYN/A

FCF(TTM)-1

FCFYN/A

OCF(TTM)-1

OCFYN/A

SpS1.71

BVpS4.45

TBVpS3.39

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.02%
ROE	-11.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	49.6%
FCFM	N/A

ROA(3y)-25.68%

ROA(5y)-18.55%

ROE(3y)-34.2%

ROE(5y)-24.45%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.03%

GM growth 5Y2.07%

F-Score3

Asset Turnover0.31

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	3.06%
Cap/Sales	0.23%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.62
Quick Ratio	6.97
Altman-Z	3.42

F-Score3

WACC9.45%

ROIC/WACCN/A

Cap/Depr(3y)75.32%

Cap/Depr(5y)61.35%

Cap/Sales(3y)3.15%

Cap/Sales(5y)2.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-3.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%15.15%

EPS Next Y34.05%

EPS Next 2Y22.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)21.06%

Revenue growth 3Y12.21%

Revenue growth 5Y27.11%

Sales Q2Q%17.88%

Revenue Next Year-4.98%

Revenue Next 2Y7.69%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y20.61%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year62.96%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-6.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-15.43%

OCF growth 3YN/A

OCF growth 5YN/A

908 DEVICES INC (MASS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens